The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity
Open accessAbstract
Quetiapine is an atypical antipsychotic drug that is also US FDA approved for treating bipolar depression, albeit by an unknown mechanism. To discover the potential mechanism for this apparently unique action, we screened quetiapine, its metabolite N-Desalkylquetiapine, and dibenzo[b,f][1,4]thiazepine-11(10-H)-one (DBTO) against a large panel of G-protein-coupled receptors, ion channels, and neurotransmitter transporters. DBTO was inactive at all tested molecular targets. N-Desalkylquetiapine had a high affinity (3.4 nM) for the histamine H(1) receptor and moderate affinities (10-100 nM) for the norepinephrine reuptake transporter (NET), the serotonin 5-HT(1A), 5-HT(1E), 5-HT(2A), 5-HT(2B), 5-HT(7) receptors, the alpha(1B)-adrenergic receptor, and the M(1), M(3), and M(5) muscarinic receptors. The compound had low affinities (100-1000 nM) for the 5-HT(1D), 5-HT(2C), 5-HT(3), 5-HT(5), 5-HT(6), alpha(1A), alpha(2A), alpha(2B), alpha(2C), H(2), M(2), M(4), and dopamine D(1), D(2), D(3), and D(4) receptors. N-Desalkylquetiapine potently inhibited human NE transporter with a K(i) of 12 nM, about 100-fold more potent than quetiapine itself. N-Desalkylquetiapine was also 10-fold more potent and more efficacious than quetiapine at the 5-HT(1A) receptor. N-Desalkylquetiapine was an antagonist at 5-HT(2A), 5-HT(2B), 5-HT(2C), alpha(1A), alpha(1D), alpha(2A), alpha(2C), H(1), M(1), M(3), and M(5) receptors. In the mouse tail suspension test, N-Desalkylquetiapine displayed potent antidepressant-like activity in VMAT2 heterozygous mice at doses as low as 0.1 mg/kg. These data strongly suggest that the antidepressant activity of quetiapine is mediated, at least in part, by its metabolite N-Desalkylquetiapine through NET inhibition and partial 5-HT(1A) agonism. Possible contributions of this metabolite to the side effects of quetiapine are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Self-citationRothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Self-citationEffectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · cited 2×
“Our results imply that the antidepressant effects of quetiapine in bipolar depression (Calabrese et al, 2005; Thase et al, 2006) are mediated, at least in part, by the potent antidepressant activity of N-Desalkylquetiapine.”
BackgroundResultKroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Self-citationSerotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Self-citationHippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
Thase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
Drugs and Valvular Heart Disease
Roth, B. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068265 · Cited by 479 · cited 7×
“For example, drug-induced valvular heart disease is frequently due to the 5-HT2B receptor agonism of metabolites (Roth, 2007; Rothman et al, 2000), while the M1 muscarinic receptor activation by the metabolite desmethylclozapine may contribute to the clinical efficacy of the antipsychotic drug clozapine (Davies et al,…”
BackgroundMethodInfluentialSelf-citationKim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
Clinical Pharmacokinetics of Quetiapine: An Atypical Antipsychotic
DeVane, C. L., & Nemeroff, C. B. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00003 · Cited by 386
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376
Self-citationRecanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
Cyclic antidepressants and the risk of sudden cardiac death
Ray, W. A., Meredith, S., Thapa, P. B., Hall, K., & Murray, K. T. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.019 · Cited by 274
Mauri, M. C., Volonteri, L. S., Colasanti, A., Fiorentini, A., De Gaspari, I. F., & Bareggi, S. R. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746050-00001 · Cited by 246
Guscott, M., Bristow, L. J., Hadingham, K., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F., Owens, A. P., Huscroft, I., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 231
Sleep-promoting properties of quetiapine in healthy subjects
Cohrs, S., Rodenbeck, A., Guan, Z., Pohlmann, K., Jordan, W., Meier, A., & R�ther, E. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1759-5 · Cited by 180
Grimm, S. W., Richtand, N. M., Winter, H. R., Stams, K. R., & Reele, S. B. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02507.x · Cited by 169
Gefvert, O., Bergström, M., Långström, B., Lundberg, T., Lindström, L., & Yates, R. (1998) · Psychopharmacology · doi:10.1007/s002130050492 · Cited by 169
Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat1 Gene
Pogorelov, V. M., Rodriguiz, R. M., Insco, M. L., Caron, M. G., & Wetsel, W. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300724 · Cited by 164
Self-citationBecker, O. M., Dhanoa, D. S., Marantz, Y., Chen, D., Shacham, S., Cheruku, S. R., Heifetz, A., Mohanty, P., Fichman, M., Sharadendu, A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508641 · Cited by 161
Vmat2 Heterozygous Mutant Mice Display a Depressive-Like Phenotype
Fukui, M., Rodriguiz, R. M., Zhou, J., Jiang, X. “., Phillips, L. E., Caron, M. G., & Wetsel, W. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4388-06.2007 · Cited by 161
Self-citationJohnson, D. E., Yamazaki, H., Ward, K. M., Schmidt, A. W., Lebel, W. S., Treadway, J. L., Gibbs, E. M., Zawalich, W. S., & Rollema, H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1552 · Cited by 151
Silvestre, J. S., & Prous, J. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.5.908643 · Cited by 143
Davies, M. A., Compton-Toth, B. A., Hufeisen, S. J., Meltzer, H. Y., & Roth, B. L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2017-1 · Cited by 128
Self-citationBalit, C. R., Isbister, G. K., Hackett, L. P., & Whyte, I. M. (2003) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(03)00600-0 · Cited by 123
Development and Evaluation of an in Silico Model for hERG Binding
Song, M., & Clark, M. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050308f · Cited by 104
Armbruster, B. N., & Roth, B. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400030200 · Cited by 88
Self-citationScreening the receptorome: an efficient approach for drug discovery and target validation
Strachan, R. T., Ferrara, G., & Roth, B. L. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.012 · Cited by 74
Self-citationGunasekara, N. S., & Spencer, C. M. (1998) · CNS Drugs · doi:10.2165/00023210-199809040-00007 · Cited by 71
Davis, P. C., Wong, J., & Gefvert, O. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(99)00036-9 · Cited by 67
Massively Parallel Screening of the Receptorome
Jensen, N., & Roth, B. L. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708784911483 · Cited by 57
Self-citationYan, B., He, J., Xu, H., Zhang, Y., Bi, X., THAKUR, S., Gendron, A., Kong, J., & LI, X. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.05.002 · Cited by 53
Quetiapine Prevents Anhedonia Induced by Acute or Chronic Stress
Orsetti, M., Canonico, P. L., Dellarole, A., Colella, L., Brisco, F. D., & Ghi, P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301291 · Cited by 53
Characterization of 5-HT1A receptor-mediated []GTPγS binding in rat hippocampal membranes
Alper, R. H., & Nelson, D. L. G. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01547-1 · Cited by 49
Single-action versus dual-action antidepressants.
Jain, R. (2004) · PubMed · Cited by 39
Setola, V., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1277 · Cited by 35
Self-citationRoth, B. L. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/broth · Cited by 16
Self-citation
Cited by
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Self-citationNelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
Ligand discovery from a dopamine D3 receptor homology model and crystal structure
Carlsson, J., Coleman, R. G., Setola, V., Irwin, J. J., Fan, H., Schlessinger, A., Sali, A., Roth, B. L., & Shoichet, B. K. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.662 · Cited by 308
Self-citation
Metadata
- Authors
- Jensen, N. H., Rodriguiz, R. M., Caron, M. G., Wetsel, W. C., Rothman, R. B., & Roth, B. L.
- Venue
- Neuropsychopharmacology
- Published
- 2007-12-05
- Volume
- 33
- Issue
- 10
- Pages
- 2303-2312
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2074852398
- Cited by
- 316
- References
- 42
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.